 | • レポートコード：MRC308GR11562 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のヒトエリスロポイン注射の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のヒトエリスロポイン注射市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ヒトエリスロポイン注射の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ヒトエリスロポイン注射市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・無色、透明、やや乳白色
用途別セグメント
・腎性貧血、非骨髄性悪性腫瘍の化学療法による貧血、その他
主要な市場プレーヤー
・Amgen、Ortho Biotech、Roche、Harbin Pharmaceutical Group Bio-vaccine、3SBio Group、Kexing Biopharm、North China Pharmaceutical Jintan Biotechnology、Kirin Kunpeng Bio-pharmaceutical、Chemo Wanbang Biopharma、Si Huan Sheng Wu
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ヒトエリスロポイン注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒトエリスロポイン注射メーカーの企業概要、2019年～2022年までのヒトエリスロポイン注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒトエリスロポイン注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ヒトエリスロポイン注射の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのヒトエリスロポイン注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒトエリスロポイン注射市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびヒトエリスロポイン注射の産業チェーンを掲載しています。
・第14、15章では、ヒトエリスロポイン注射の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ヒトエリスロポイン注射の概要
– 種類別分析（2018年vs2022年vs2029年）：無色、透明、やや乳白色
– 用途別分析（2018年vs2022年vs2029年）：腎性貧血、非骨髄性悪性腫瘍の化学療法による貧血、その他
– 世界のヒトエリスロポイン注射市場規模・予測
– 世界のヒトエリスロポイン注射生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Amgen、Ortho Biotech、Roche、Harbin Pharmaceutical Group Bio-vaccine、3SBio Group、Kexing Biopharm、North China Pharmaceutical Jintan Biotechnology、Kirin Kunpeng Bio-pharmaceutical、Chemo Wanbang Biopharma、Si Huan Sheng Wu
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：無色、透明、やや乳白色
・用途別分析2018年-2029年：腎性貧血、非骨髄性悪性腫瘍の化学療法による貧血、その他
・ヒトエリスロポイン注射の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒトエリスロポイン注射のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒトエリスロポイン注射のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒトエリスロポイン注射の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒトエリスロポイン注射の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Human Erythropoin Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Erythropoin Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Colorless
1.3.3 Clarify
1.3.4 Slightly Milky
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Erythropoin Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Anemia Due to Renal Insufficiency
1.4.3 Anemia Induced by Chemotherapy in Non-myeloid Malignancies
1.4.4 Others
1.5 Global Human Erythropoin Injection Market Size & Forecast
1.5.1 Global Human Erythropoin Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Erythropoin Injection Sales Quantity (2018-2029)
1.5.3 Global Human Erythropoin Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Human Erythropoin Injection Product and Services
2.1.4 Amgen Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen Recent Developments/Updates
2.2 Ortho Biotech
2.2.1 Ortho Biotech Details
2.2.2 Ortho Biotech Major Business
2.2.3 Ortho Biotech Human Erythropoin Injection Product and Services
2.2.4 Ortho Biotech Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ortho Biotech Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Human Erythropoin Injection Product and Services
2.3.4 Roche Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments/Updates
2.4 Harbin Pharmaceutical Group Bio-vaccine
2.4.1 Harbin Pharmaceutical Group Bio-vaccine Details
2.4.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
2.4.3 Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Product and Services
2.4.4 Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
2.5 3SBio Group
2.5.1 3SBio Group Details
2.5.2 3SBio Group Major Business
2.5.3 3SBio Group Human Erythropoin Injection Product and Services
2.5.4 3SBio Group Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 3SBio Group Recent Developments/Updates
2.6 Kexing Biopharm
2.6.1 Kexing Biopharm Details
2.6.2 Kexing Biopharm Major Business
2.6.3 Kexing Biopharm Human Erythropoin Injection Product and Services
2.6.4 Kexing Biopharm Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kexing Biopharm Recent Developments/Updates
2.7 North China Pharmaceutical Jintan Biotechnology
2.7.1 North China Pharmaceutical Jintan Biotechnology Details
2.7.2 North China Pharmaceutical Jintan Biotechnology Major Business
2.7.3 North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Product and Services
2.7.4 North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 North China Pharmaceutical Jintan Biotechnology Recent Developments/Updates
2.8 Kirin Kunpeng Bio-pharmaceutical
2.8.1 Kirin Kunpeng Bio-pharmaceutical Details
2.8.2 Kirin Kunpeng Bio-pharmaceutical Major Business
2.8.3 Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Product and Services
2.8.4 Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Kirin Kunpeng Bio-pharmaceutical Recent Developments/Updates
2.9 Chemo Wanbang Biopharma
2.9.1 Chemo Wanbang Biopharma Details
2.9.2 Chemo Wanbang Biopharma Major Business
2.9.3 Chemo Wanbang Biopharma Human Erythropoin Injection Product and Services
2.9.4 Chemo Wanbang Biopharma Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Chemo Wanbang Biopharma Recent Developments/Updates
2.10 Si Huan Sheng Wu
2.10.1 Si Huan Sheng Wu Details
2.10.2 Si Huan Sheng Wu Major Business
2.10.3 Si Huan Sheng Wu Human Erythropoin Injection Product and Services
2.10.4 Si Huan Sheng Wu Human Erythropoin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Si Huan Sheng Wu Recent Developments/Updates
3 Competitive Environment: Human Erythropoin Injection by Manufacturer
3.1 Global Human Erythropoin Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Erythropoin Injection Revenue by Manufacturer (2018-2023)
3.3 Global Human Erythropoin Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Erythropoin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Erythropoin Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Human Erythropoin Injection Manufacturer Market Share in 2022
3.5 Human Erythropoin Injection Market: Overall Company Footprint Analysis
3.5.1 Human Erythropoin Injection Market: Region Footprint
3.5.2 Human Erythropoin Injection Market: Company Product Type Footprint
3.5.3 Human Erythropoin Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Erythropoin Injection Market Size by Region
4.1.1 Global Human Erythropoin Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Human Erythropoin Injection Consumption Value by Region (2018-2029)
4.1.3 Global Human Erythropoin Injection Average Price by Region (2018-2029)
4.2 North America Human Erythropoin Injection Consumption Value (2018-2029)
4.3 Europe Human Erythropoin Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Human Erythropoin Injection Consumption Value (2018-2029)
4.5 South America Human Erythropoin Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Human Erythropoin Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Erythropoin Injection Sales Quantity by Type (2018-2029)
5.2 Global Human Erythropoin Injection Consumption Value by Type (2018-2029)
5.3 Global Human Erythropoin Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Erythropoin Injection Sales Quantity by Application (2018-2029)
6.2 Global Human Erythropoin Injection Consumption Value by Application (2018-2029)
6.3 Global Human Erythropoin Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Human Erythropoin Injection Sales Quantity by Type (2018-2029)
7.2 North America Human Erythropoin Injection Sales Quantity by Application (2018-2029)
7.3 North America Human Erythropoin Injection Market Size by Country
7.3.1 North America Human Erythropoin Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Human Erythropoin Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Erythropoin Injection Sales Quantity by Type (2018-2029)
8.2 Europe Human Erythropoin Injection Sales Quantity by Application (2018-2029)
8.3 Europe Human Erythropoin Injection Market Size by Country
8.3.1 Europe Human Erythropoin Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Erythropoin Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Erythropoin Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Erythropoin Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Erythropoin Injection Market Size by Region
9.3.1 Asia-Pacific Human Erythropoin Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Erythropoin Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Erythropoin Injection Sales Quantity by Type (2018-2029)
10.2 South America Human Erythropoin Injection Sales Quantity by Application (2018-2029)
10.3 South America Human Erythropoin Injection Market Size by Country
10.3.1 South America Human Erythropoin Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Human Erythropoin Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Erythropoin Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Erythropoin Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Erythropoin Injection Market Size by Country
11.3.1 Middle East & Africa Human Erythropoin Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Erythropoin Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Erythropoin Injection Market Drivers
12.2 Human Erythropoin Injection Market Restraints
12.3 Human Erythropoin Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Erythropoin Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Erythropoin Injection
13.3 Human Erythropoin Injection Production Process
13.4 Human Erythropoin Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Erythropoin Injection Typical Distributors
14.3 Human Erythropoin Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Human Erythropoin Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Erythropoin Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Human Erythropoin Injection Product and Services
Table 6. Amgen Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amgen Recent Developments/Updates
Table 8. Ortho Biotech Basic Information, Manufacturing Base and Competitors
Table 9. Ortho Biotech Major Business
Table 10. Ortho Biotech Human Erythropoin Injection Product and Services
Table 11. Ortho Biotech Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ortho Biotech Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche Human Erythropoin Injection Product and Services
Table 16. Roche Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roche Recent Developments/Updates
Table 18. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 19. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 20. Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Product and Services
Table 21. Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 23. 3SBio Group Basic Information, Manufacturing Base and Competitors
Table 24. 3SBio Group Major Business
Table 25. 3SBio Group Human Erythropoin Injection Product and Services
Table 26. 3SBio Group Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. 3SBio Group Recent Developments/Updates
Table 28. Kexing Biopharm Basic Information, Manufacturing Base and Competitors
Table 29. Kexing Biopharm Major Business
Table 30. Kexing Biopharm Human Erythropoin Injection Product and Services
Table 31. Kexing Biopharm Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kexing Biopharm Recent Developments/Updates
Table 33. North China Pharmaceutical Jintan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. North China Pharmaceutical Jintan Biotechnology Major Business
Table 35. North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Product and Services
Table 36. North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. North China Pharmaceutical Jintan Biotechnology Recent Developments/Updates
Table 38. Kirin Kunpeng Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Kirin Kunpeng Bio-pharmaceutical Major Business
Table 40. Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Product and Services
Table 41. Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Kirin Kunpeng Bio-pharmaceutical Recent Developments/Updates
Table 43. Chemo Wanbang Biopharma Basic Information, Manufacturing Base and Competitors
Table 44. Chemo Wanbang Biopharma Major Business
Table 45. Chemo Wanbang Biopharma Human Erythropoin Injection Product and Services
Table 46. Chemo Wanbang Biopharma Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Chemo Wanbang Biopharma Recent Developments/Updates
Table 48. Si Huan Sheng Wu Basic Information, Manufacturing Base and Competitors
Table 49. Si Huan Sheng Wu Major Business
Table 50. Si Huan Sheng Wu Human Erythropoin Injection Product and Services
Table 51. Si Huan Sheng Wu Human Erythropoin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Si Huan Sheng Wu Recent Developments/Updates
Table 53. Global Human Erythropoin Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Human Erythropoin Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Human Erythropoin Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Human Erythropoin Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Human Erythropoin Injection Production Site of Key Manufacturer
Table 58. Human Erythropoin Injection Market: Company Product Type Footprint
Table 59. Human Erythropoin Injection Market: Company Product Application Footprint
Table 60. Human Erythropoin Injection New Market Entrants and Barriers to Market Entry
Table 61. Human Erythropoin Injection Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Erythropoin Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Human Erythropoin Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Human Erythropoin Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Human Erythropoin Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Human Erythropoin Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Human Erythropoin Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Human Erythropoin Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Human Erythropoin Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Human Erythropoin Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Human Erythropoin Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Human Erythropoin Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Human Erythropoin Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Human Erythropoin Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Human Erythropoin Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Human Erythropoin Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Human Erythropoin Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Human Erythropoin Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Human Erythropoin Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Human Erythropoin Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Human Erythropoin Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Human Erythropoin Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Human Erythropoin Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Human Erythropoin Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Human Erythropoin Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Human Erythropoin Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Human Erythropoin Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Human Erythropoin Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Human Erythropoin Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Human Erythropoin Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Human Erythropoin Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Human Erythropoin Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Human Erythropoin Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Human Erythropoin Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Human Erythropoin Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Human Erythropoin Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Human Erythropoin Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Human Erythropoin Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Human Erythropoin Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Human Erythropoin Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Human Erythropoin Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Human Erythropoin Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Human Erythropoin Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Human Erythropoin Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Human Erythropoin Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Human Erythropoin Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Human Erythropoin Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Human Erythropoin Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Human Erythropoin Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Human Erythropoin Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Human Erythropoin Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Human Erythropoin Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Human Erythropoin Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Human Erythropoin Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Human Erythropoin Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Human Erythropoin Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Human Erythropoin Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Human Erythropoin Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Human Erythropoin Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Human Erythropoin Injection Raw Material
Table 121. Key Manufacturers of Human Erythropoin Injection Raw Materials
Table 122. Human Erythropoin Injection Typical Distributors
Table 123. Human Erythropoin Injection Typical Customers
List of Figures
Figure 1. Human Erythropoin Injection Picture
Figure 2. Global Human Erythropoin Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Erythropoin Injection Consumption Value Market Share by Type in 2022
Figure 4. Colorless Examples
Figure 5. Clarify Examples
Figure 6. Slightly Milky Examples
Figure 7. Global Human Erythropoin Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Human Erythropoin Injection Consumption Value Market Share by Application in 2022
Figure 9. Anemia Due to Renal Insufficiency Examples
Figure 10. Anemia Induced by Chemotherapy in Non-myeloid Malignancies Examples
Figure 11. Others Examples
Figure 12. Global Human Erythropoin Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Human Erythropoin Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Human Erythropoin Injection Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Human Erythropoin Injection Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Human Erythropoin Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Human Erythropoin Injection Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Human Erythropoin Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Human Erythropoin Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Human Erythropoin Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Human Erythropoin Injection Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Human Erythropoin Injection Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Human Erythropoin Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Human Erythropoin Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Human Erythropoin Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Human Erythropoin Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Human Erythropoin Injection Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Human Erythropoin Injection Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Human Erythropoin Injection Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Human Erythropoin Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Human Erythropoin Injection Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Human Erythropoin Injection Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Human Erythropoin Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Human Erythropoin Injection Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Human Erythropoin Injection Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Human Erythropoin Injection Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Human Erythropoin Injection Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Human Erythropoin Injection Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Human Erythropoin Injection Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Human Erythropoin Injection Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Human Erythropoin Injection Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Human Erythropoin Injection Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Human Erythropoin Injection Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Human Erythropoin Injection Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Human Erythropoin Injection Consumption Value Market Share by Region (2018-2029)
Figure 54. China Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Human Erythropoin Injection Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Human Erythropoin Injection Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Human Erythropoin Injection Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Human Erythropoin Injection Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Human Erythropoin Injection Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Human Erythropoin Injection Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Human Erythropoin Injection Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Human Erythropoin Injection Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Human Erythropoin Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Human Erythropoin Injection Market Drivers
Figure 75. Human Erythropoin Injection Market Restraints
Figure 76. Human Erythropoin Injection Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Erythropoin Injection in 2022
Figure 79. Manufacturing Process Analysis of Human Erythropoin Injection
Figure 80. Human Erythropoin Injection Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source